Lisbeth Hansen

Lisbeth Hansen is an accomplished professional in the field of pharmacovigilance and safety medical writing, currently serving as a Safety Medical Writing Specialist at Novo Nordisk since December 2024. Prior to this role, Lisbeth held various positions at LEO Pharma from March 2014 to December 2024, including Manager of Global Safety Surveillance and Regulatory Lead in the Marketed Products Unit, where responsibilities included global compliance tracking and monitoring of adverse event submissions. Earlier in the career, Lisbeth worked as a GCP coordinator at the GCP unit in Copenhagen, focusing on monitoring investigator-initiated studies and advising on regulatory protocol writing. Lisbeth holds a Master's degree in Medicine with Industrial Specialization and a Bachelor of Science in Medicine with Industrial Specialization, both from Aalborg University.